Results 111 to 120 of about 251,846 (313)
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
Catalytic selective oxidation of propane to acrylic acid in a fixed-bed reactor with an O2-distributor [PDF]
Propane selective oxidation to acrylic acid was carried out by sequential oxidative dehydrogenation (ODH) of propane and selective oxidation to acrylic acid (SOA) of propylene steps, using a two-catalyst bed. A novel approach to improving the selectivity
俞佳枫, 徐恒泳, 葛庆杰, 方雯
core
The oxygen activated by the active vanadium species for the selective oxidation of benzene to phenol [PDF]
The activation of oxygen is a key step for the selective oxidation of benzene to phenol and the reason is discussed. The active oxygen species is produced from molecular oxygen in a so-called "reductive activation" process.
Xu, Jie, Gao, Xiaohan, 徐杰
core +1 more source
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
Surface-mediated selective photocatalytic aerobic oxidation reactions on TiO2 nanofibres [PDF]
N-doped TiO2 nanofibres were observed to possess lower aerobic oxidation activity than undoped TiO2 nanofibres in the selective photocatalytic aerobic oxidation of enzylamine and 4-methoxybenzyl alcohol.
Jia, Jianfeng +9 more
core +1 more source
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
PANoptosis in the pathogenesis of myelodysplastic syndromes
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla +4 more
wiley +1 more source
Highly effective CuO Fe(OH)x catalysts for selective oxidation of CO in H2-rich stream [PDF]
Highly effective CuO/Fe(OH)x catalysts for selective oxidation of CO in H2-rich ...
张涛 +5 more
core
ADP‐ribosylation: An emerging regulator of the epigenome
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho +2 more
wiley +1 more source

